Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M41.3Revenue (TTM) $M--Net Margin (%)--Altman Z-Score22.8
Enterprise Value $M22.6EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %--Quick Ratio28.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio28.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-63.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M46.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PTIE is held by these investors:



PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy50,000$3.73-77.75view
FRIEDMANN NADAVCOO 2011-10-18Sell25,000$4.44-81.31view
FRIEDMANN NADAVCOO 2011-10-04Sell25,000$4.81-82.74view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell382,000$4.59-81.92view
FRIEDMANN NADAVCOO 2011-09-15Sell25,000$4.89-83.03view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell44,417$4.2-80.24view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy5,000$4.22-80.33view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell50,000$6.2-86.61view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell28,597$5.69-85.41view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell21,403$5.81-85.71view

Press Releases about PTIE :

Quarterly/Annual Reports about PTIE:

News about PTIE:

Articles On GuruFocus.com
Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE May 13 2015 
Eveillard's First Eagle Increases 2 Positions Sep 11 2014 
Morning Coffee: Real-Time Picks May 14 2014 
Pain Therapeutics Reports Operating Results (10-K) Feb 03 2011 
Pain Therapeutics Reports Operating Results (10-Q) Oct 29 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares Oct 04 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 28,597 Shares Sep 08 2010 
Pain Therapeutics (ptie) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 21,403 Shares Sep 02 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 22,391 Shares Aug 04 2010 
Pain Therapeutics Reports Operating Results (10-Q) Jul 29 2010 

More From Other Websites
PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events Mar 21 2017
Pain Therapeutics’ Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT) Mar 21 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY™ ER Mar 20 2017
PAIN THERAPEUTICS INC Financials Mar 11 2017
PAIN THERAPEUTICS INC Files SEC form 10-K, Annual Report Mar 07 2017
Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means Feb 21 2017
Pain Therapeutics reports 4Q loss Feb 17 2017
Pain Therapeutics reports 4Q loss Feb 17 2017
PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 17 2017
Pain Therapeutics Reports 2016 Financial Results Feb 17 2017
Pain Therapeutics to Discuss REMOXY® ER with FDA Dec 20 2016
Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers? Dec 16 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Dec 08 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 18 2016
Durect (DRRX) Exited Third Quarter with Strong Balance Sheet Nov 01 2016
PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Oct 26 2016
Pain Therapeutics Reports Q3 2016 Financial Results Oct 20 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 20 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Oct 11 2016
Pain Therapeutics (PTIE) Enters Oversold Territory Sep 29 2016
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug Sep 28 2016
Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection Sep 26 2016
5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy Sep 26 2016
GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making... Sep 26 2016
For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million Sep 26 2016
Complete Response Letter for REMOXY® Sep 26 2016
Pain Therapeutics Announces Advisory Committee Meeting for REMOXY® Is Not Needed Jul 01 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® May 19 2016
Pain Therapeutics Reports Q1 2016 Financial Results May 05 2016
FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of September 25, 2016 Apr 12 2016
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration Mar 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)